A MOUSE CDC25 HOMOLOG IS DIFFERENTIALLY AND DEVELOPMENTALLY EXPRESSED

被引:69
|
作者
KAKIZUKA, A
SEBASTIAN, B
BORGMEYER, U
HERMANSBORGMEYER, I
BOLADO, J
HUNTER, T
HOEKSTRA, MF
EVANS, RM
机构
[1] UNIV CALIF SAN DIEGO, LA JOLLA, CA 92093 USA
[2] SALK INST BIOL STUDIES, MOLEC BIOL & VIROL LAB, LA JOLLA, CA 92037 USA
[3] SALK INST BIOL STUDIES, HOWARD HUGHES MED INST, LA JOLLA, CA 92037 USA
关键词
CDC25M2; MOUSE; DEVELOPMENTAL EXPRESSION; CELL-CYCLE-DEPENDENT EXPRESSION; PHOSPHATASE;
D O I
10.1101/gad.6.4.578
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The timing and activation of the p34cdc2 kinase in mammals is associated with dephosphorylation of phosphotyrosine and phosphothreonine residues on the p34cdc2 kinase. For fission yeast, the timing of mitosis is regulated by cyclic accumulation of cdc25, which promotes dephosphorylation of p34cdc2 and concomitant protein kinase activation. We report the identification and characterization of a structural and functional mouse homolog, Cdc25M2, of the cdc25 phosphatase. Cdc25M2 shows high sequence identity to the previously reported human homolog cdc25Hu2. Cdc25M2 can functionally complement for a Schizosaccharomyces pombe cdc25ts mutation, and when expressed in Escherichia coli and purified, Cdc25M2 is an active phosphatase. cdc25M2 mRNA shows variation in expression in different tissues in the mouse embryo and is expressed in a developmental and cell-cycle-dependent fashion. We suggest that the expression and accumulation of the cdc25 mitotic inducer may play a critical role in the regulation of mouse development.
引用
收藏
页码:578 / 590
页数:13
相关论文
共 50 条
  • [31] Dual mode of degradation of Cdc25 A phosphatase
    Donzelli, M
    Squatrito, M
    Ganoth, D
    Hershko, A
    Pagano, M
    Draetta, GF
    EMBO JOURNAL, 2002, 21 (18): : 4875 - 4884
  • [32] Cdc25 protein phosphatases in cell proliferation
    Draetta, G.
    Eckstein, J.
    B B A - Biomembranes, 1332 (02):
  • [33] CDC25 PHOSPHATASES AS POTENTIAL HUMAN ONCOGENES
    GALAKTIONOV, K
    LEE, AK
    ECKSTEIN, J
    DRAETTA, G
    MECKLER, J
    LODA, M
    BEACH, D
    SCIENCE, 1995, 269 (5230) : 1575 - 1577
  • [34] Cdc25 as a Potential Target of Anticancer Agents
    Jens W. Eckstein
    Investigational New Drugs, 2000, 18 : 149 - 156
  • [35] Cell Cycle Control by the CDC25 Phosphatases
    Aressy, Bernadette
    Ducommun, Bernard
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (08) : 818 - 824
  • [36] Cdc25 protein phosphatases in cell proliferation
    Draetta, G
    Eckstein, J
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1332 (02): : M53 - M63
  • [37] Design of covalent inhibitors of Cdc25 phosphatases
    Muus, Ulrike
    Lountos, George T.
    Waugh, David S.
    Burke, Terrence R., Jr.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [38] Cdc25: mechanisms of checkpoint inhibition and recovery
    Karisson-Rosenthal, Christina
    Millar, Jonathan B. A.
    TRENDS IN CELL BIOLOGY, 2006, 16 (06) : 285 - 292
  • [39] Flexibility and inhibitor binding in Cdc25 phosphatases
    Arantes, Guilherme Menegon
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (14) : 3017 - 3032
  • [40] Targeting CDC25 phosphatases in cancer therapy
    Ducommun, B.
    Prevost, G.
    Cazales, M.
    Brezak, M.
    Boutros, R.
    Contour-Galcera, M.
    Chaumeron, S.
    Quaranta, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 89 - 89